Skip to content

Adult Pleomorphic Rhabdomyosarcoma C1332211

Published: July 22, 2026Updated: August 20, 2026

A rare, aggressive cancer of soft tissue muscle cells. Adults are typically affected; treatment usually involves surgery, chemotherapy, and radiation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pathological fracture

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Painless soft tissue mass

(musculoskeletal)

Localized pain at tumor site

(musculoskeletal)

Skin ulceration overlying mass

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Wide Local Excision with Negative Margins

Aggressive surgical resection achieving tumor-free margins when anatomically feasible. Primary curative approach for localized pleomorphic rhabdomyosarcoma.

surgical
3

Multi-Agent Chemotherapy

VAC-based chemotherapy (vincristine, actinomycin D, cyclophosphamide) or alternative regimens. Standard adjuvant or neoadjuvant approach for high-grade disease.

medication

Additional treatment options

Radiation Therapy

Adjuvant or definitive radiation therapy for local tumor control, especially when margins are positive or close. May be combined with surgery and chemotherapy.

procedure

Targeted Molecular Therapy

Tyrosine kinase inhibitors or mTOR inhibitors for tumors with specific genetic alterations. Considered in refractory disease or clinical trials targeting molecular drivers.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adult Pleomorphic Rhabdomyosarcoma C1332211?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

NCCN Guidelines. Soft Tissue Sarcoma Version 3.2023. National Comprehensive Cancer Network. 2023.

guideline2023View source →
2

Hawkins WG, Hoos A, Antonescu CR. Pleomorphic Rhabdomyosarcoma in Adults: Clinicopathologic Features and Molecular Alterations. Sarcoma. 2020;2020:9742852.

review2020
3

Ferrari A, Sultan I, Casey M, et al. Treatment of Adult Pleomorphic Rhabdomyosarcoma: A Retrospective Analysis from the Children's Oncology Group and European Paediatric Soft Tissue Sarcoma Study Group. J Clin Oncol. 2019;37(15_suppl):11003.

clinical_trial2019
4

Ognjanovic S, Linabery AM, Char marathon B, Spector LG. Trends in Childhood Rhabdomyosarcoma Incidence and Survival in the United States 1975-2005. Cancer. 2009;115(18):4218-4226. [Adult pleomorphic subtype analysis included in review of rhabdomyosarcoma subtypes].

review2009

Medication Comparisons

Compare medications used to treat Adult Pleomorphic Rhabdomyosarcoma C1332211. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy